1. Home
  2. FOLD vs MHO Comparison

FOLD vs MHO Comparison

Compare FOLD & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • MHO
  • Stock Information
  • Founded
  • FOLD 2002
  • MHO 1976
  • Country
  • FOLD United States
  • MHO United States
  • Employees
  • FOLD N/A
  • MHO N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • MHO Homebuilding
  • Sector
  • FOLD Health Care
  • MHO Consumer Discretionary
  • Exchange
  • FOLD Nasdaq
  • MHO Nasdaq
  • Market Cap
  • FOLD 2.9B
  • MHO 3.1B
  • IPO Year
  • FOLD 2007
  • MHO 1986
  • Fundamental
  • Price
  • FOLD $6.08
  • MHO $110.81
  • Analyst Decision
  • FOLD Buy
  • MHO Strong Buy
  • Analyst Count
  • FOLD 10
  • MHO 3
  • Target Price
  • FOLD $16.22
  • MHO $158.67
  • AVG Volume (30 Days)
  • FOLD 4.6M
  • MHO 224.8K
  • Earning Date
  • FOLD 05-01-2025
  • MHO 04-23-2025
  • Dividend Yield
  • FOLD N/A
  • MHO N/A
  • EPS Growth
  • FOLD N/A
  • MHO 9.13
  • EPS
  • FOLD N/A
  • MHO 18.93
  • Revenue
  • FOLD $543,141,000.00
  • MHO $4,434,060,000.00
  • Revenue This Year
  • FOLD $21.87
  • MHO $3.47
  • Revenue Next Year
  • FOLD $22.19
  • MHO $5.11
  • P/E Ratio
  • FOLD N/A
  • MHO $5.76
  • Revenue Growth
  • FOLD 28.25
  • MHO 8.69
  • 52 Week Low
  • FOLD $6.20
  • MHO $100.22
  • 52 Week High
  • FOLD $12.65
  • MHO $176.18
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 29.58
  • MHO 52.89
  • Support Level
  • FOLD $6.63
  • MHO $107.36
  • Resistance Level
  • FOLD $7.71
  • MHO $111.38
  • Average True Range (ATR)
  • FOLD 0.30
  • MHO 3.39
  • MACD
  • FOLD -0.05
  • MHO 0.88
  • Stochastic Oscillator
  • FOLD 13.76
  • MHO 71.17

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

Share on Social Networks: